Pharmaceutical Research Center, Advanced Drug Discovery, Asahi Kasei Pharma Corporation, Shizuoka, Japan.
RIKEN Center for Biosystems Dynamics Research, Tsurumi-ku, Yokohama, Kanagawa, Japan.
J Comput Chem. 2022 Jul 30;43(20):1362-1371. doi: 10.1002/jcc.26940. Epub 2022 Jun 9.
Fragment molecular orbital (FMO) method is a powerful computational tool for structure-based drug design, in which protein-ligand interactions can be described by the inter-fragment interaction energy (IFIE) and its pair interaction energy decomposition analysis (PIEDA). Here, we introduced a dynamically averaged (DA) FMO-based approach in which molecular dynamics simulations were used to generate multiple protein-ligand complex structures for FMO calculations. To assess this approach, we examined the correlation between the experimental binding free energies and DA-IFIEs of six CDK2 inhibitors whose net charges are zero. The correlation between the experimental binding free energies and snapshot IFIEs for X-ray crystal structures was R = 0.75. Using the DA-IFIEs, the correlation significantly improved to 0.99. When an additional CDK2 inhibitor with net charge of -1 was added, the DA FMO-based scheme with the dispersion energies still achieved R = 0.99, whereas R decreased to 0.32 employing all the energy terms of PIEDA.
片段分子轨道(FMO)方法是一种强大的基于结构的药物设计计算工具,其中蛋白质-配体相互作用可以通过片段间相互作用能(IFIE)及其对相互作用能分解分析(PIEDA)来描述。在这里,我们引入了一种动态平均(DA)的 FMO 方法,该方法使用分子动力学模拟生成多个蛋白质-配体复合物结构进行 FMO 计算。为了评估该方法,我们考察了六个 CDK2 抑制剂的实验结合自由能与 DA-IFIE 之间的相关性,这些抑制剂的净电荷为零。X 射线晶体结构的实验结合自由能与快照 IFIE 之间的相关性为 R = 0.75。使用 DA-IFIE,相关性显著提高到 0.99。当加入另一个净电荷为-1 的 CDK2 抑制剂时,包含色散能的基于 DA FMO 的方案仍能达到 R = 0.99,而采用 PIEDA 的所有能量项时,R 降低至 0.32。